Endovia Health Sciences, Inc. (EDVA)
NYSEAMERICAN: EDVA · Real-Time Price · USD
0.1470
+0.0069 (4.93%)
At close: Oct 15, 2026, 4:00 PM EDT
0.1341
-0.0129 (-8.78%)
Pre-market: Oct 16, 2026, 4:45 AM EDT
Endovia Health Sciences Employees
As of December 31, 2025, Endovia Health Sciences had 2 total employees, including 1 full-time and 1 part-time employees. The number of employees decreased by 19 or -90.48% compared to the previous year. That makes Endovia Health Sciences the 43,252nd largest employer in the world and 7,003rd in the United States.
Employees
2
Change (1Y)
-19
Growth (1Y)
-90.48%
Revenue / Employee
$16,045
Profits / Employee
-$9,417,950
Market Cap
942.64K
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 2 | -19 | -90.48% | 1 | 1 |
| Dec 31, 2024 | 21 | -11 | -34.38% | 21 | 0 |
| Dec 31, 2023 | 32 | -8 | -20.00% | 32 | 0 |
| Dec 31, 2022 | 40 | 19 | 90.48% | 40 | 0 |
| Dec 31, 2021 | 21 | - | - | 21 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Valion Bio | 52 |
| Scinai Immunotherapeutics | 45 |
| Virax Biolabs Group | 26 |
| Curis | 24 |
| Silexion Therapeutics | 14 |
| BioRestorative Therapies | 14 |
| Decoy Therapeutics | 11 |
| Artelo Biosciences | 7 |
EDVA News
- 7 days ago - Endovia Health Sciences Proxy statement: Proxy filing - Filings
- 10 days ago - Endovia Health Sciences announces FDA minor-use determination for CannEpil - TheFly
- 10 days ago - Endovia and Lupvindol BioSciences Announce FDA Determination that CannEpil® for Canine Bone Cancer Pain Qualifies as a Minor Use, Establishing Eligibility for Conditional Approval Pathway - GlobeNewsWire
- 10 days ago - Endovia Health Sciences Proxy statement: Proxy filing - Filings
- 22 days ago - Endovia Health Sciences Proxy statement: Proxy filing - Filings
- 23 days ago - Endovia Health Sciences Closes Initial Funding to Accelerate CannEpil® Development Amid Growing Federal Support for Botanical Drug Pathways - GlobeNewsWire
- 27 days ago - Endovia Health Sciences Proxy statement: Proxy filing - Filings
- 6 weeks ago - Endovia Health Sciences Welcomes Historic Shift in Federal Cannabinoid Policy; Advances CannEpil® FDA Submission and Expands Development Pipeline - GlobeNewsWire